(2-Fluoro-3-methylpyridine-5-yl)boronic acid, 95.0%, 100g

MOXIFLOXACIN, 95%, 1g

(S)-4-Benzyl-3-(5-bromopentanoyl)oxazolidin-2-one, 98%, 5g

methyl 5-chloro-6-(hydroxymethyl)nicotinate, 95+%, 100mg

Dimethyldivinylsilane, 95%, 1g

Methyl 4-Hydroxy-3,5-dimethoxybenzoate>98.0%(GC)25g

(S)-3-((TERT-BUTYLDIMETHYLSILYL)OXY)PYRROLIDIN-2-ONE, 95.0%, 100mg

Ethyl 9,9-dimethyl-8-oxodecanoate, 97.0%, 2g

N-(2-Bromo-4-nitrophenyl)acetamide, 95.0%, 1g

(2S,3R)-METHYL 3-AMINO-2-HYDROXY-3-PHENYLPROPANOATE, 95.0%, 250mg

7-{[(benzyloxy)carbonyl]amino}heptanoic acid, 97%, 250mg

(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-(4-hydroxycyclohexyl)acetic acid, 98%, 250mg

H-Glu-OMe, 95%, 100g